elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Lymph node
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Lymph node
RIS
0.004
(Research Intensity Score)
Papers
548
Top papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 · 2159 citations
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
2023 · 106 citations
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
2020 · 295 citations
Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.
2026 · 12 citations
Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green
2022 · 84 citations
Node Reporting and Data System 1.0 (Node-RADS) for the Assessment of Oncological Patients’ Lymph Nodes in Clinical Imaging
2025 · 18 citations
SAGES 2025 systematic review and meta-analysis for fluorescence image-guided gastrointestinal surgery using indocyanine green
2025 · 8 citations
Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study
2023 · 47 citations
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial
2025 · 10 citations
Newest papers
Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.
2026 · 12 citations
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients: A Pediatric Surgical Oncology Research Collaborative prospective observational study
2026 · 3 citations
Evaluating the impact of partial volume correction on FDG PET radiomics stability in lymphoma lesions
2026 · 2 citations
Predicting axillary lymph node metastasis in clinical T1/2 stage breast cancer using iodine map-derived multi-region radiomics and multi-modality imaging characteristics
2026 · 2 citations
Targeted Therapy or Chemotherapy First? A Meta-Analysis in Resectable EGFR-Mutant Non-Small Cell Lung Cancer
2026
Clinical case of liver metastasis in 15-year-old adolescent with papillary thyroid carcinoma
2026
Postoperative adjuvant chemoradiation versus adjuvant radiation in surgically managed HPV-mediated OPSCC: a ten-year study using 8th edition AJCC pathologic staging
2026
Risk factors associated with lymph node metastasis in cN0 papillary thyroid microcarcinoma
2026
Treatment Strategies for Extramammary Paget Disease: A Narrative Review of Current Status and Future Directions
2026
Browse all papers →
Lymph node's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Lymph node's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link